Their study identified AGR3 as an estrogen-responsive gene through Gene Set Enrichment Analysis (GSEA) and demonstrated that AGR3 knockdown reduced cell viability, suggesting a role for AGR3 in promoting the viability of estrogen receptor-positive breast cancer cells. The gene discussed is AGR3; the disease is breast carcinoma.